Prognosis of ischemia recurrence in patients with moderate intracranial atherosclerotic disease using quantitative MRA measurements.
Prognosis of ischemia recurrence in patients with moderate intracranial atherosclerotic disease using quantitative MRA measurements.
复制标题
使用定量 MRA 测量对中度颅内动脉粥样硬化性疾病患者的缺血复发进行预后。
DOI:
10.1117/12.2611462
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Ionita,CiprianN
中科院分区:
文献类型:
--
作者:
Joseph,Jeff;Weppner,Benjamin;Pinter,NandorK;ShirazBhurwani,MohammadMahdi;Monteiro,Andre;Baig,Ammad;Davies,Jason;Siddiqui,Adnan;Ionita,CiprianN
PurposeTo investigate the relation between delayed ischemic stroke and the intracranial atherosclerotic disease (ICAD) hemodynamics as determined by Non-invasive Optimal Vessel Analysis (NOVA) MRI measurements.Materials and MethodsThirty-three patients with ICAD were enrolled in this study. All patients underwent clinically indicated angioplasty followed by 2-dimensional phase contrast MR (2D PCMR) performed on a 3.0 Tesla MRI scanner using either a 16-channel neurovascular coil or 32-channel head coil. The volumetric flow rate measurements were calculated from 2D PCMR with Non-invasive Optimal Vessel Analysis (NOVA) software (VasSol, Chicago, IL, USA). Flow rate measurements were obtained in 20 major arteries distal, proximal and within the Circle of Willis. Patients were followed up for six month, and ischemia reoccurrence and location were recorded. Receiver operating characteristic (ROC) analysis was performed using flow rates measurements in the ipsilateral side of the ischemic event occurrence. Results Complete set of measurements was achieved in n=34. Left and right hemisphere ischemia recurrence was observed in seven and three cases respectively. Best predictor of ischemic event reoccurrence was flow rate in the middle cerebral artery with area under the ROC of 0.821±0.109.ConclusionsThis is an effectiveness study to determine whether blood flow measurements in the intracranial vasculature may be predictive of future ischemic events. Our results demonstrated significant correlation between the blood flow measurements using 2D PCMR processed with the NOVA software and the reoccurrence of ischemia. These results support further investigation for using this method for risk stratification of ICAD patients.